AllianceBernstein’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.6M Sell
1,290,087
-323,338
-20% -$18.3M 0.02% 571
2025
Q4
$67M Sell
1,613,425
-524,694
-25% -$21.7M 0.02% 538
2025
Q3
$86.1M Sell
2,138,119
-26,095
-1% -$759K 0.03% 460
2025
Q2
$56.3M Buy
2,164,214
+281,637
+15% +$6.79M 0.02% 572
2025
Q1
$46.1M Buy
1,882,577
+64,690
+4% +$1.82M 0.02% 606
2024
Q4
$52.1M Buy
1,817,887
+692,982
+62% +$23.7M 0.02% 580
2024
Q3
$42.4M Buy
1,124,905
+115,122
+11% +$4.04M 0.01% 658
2024
Q2
$31.9M Buy
1,009,783
+80,031
+9% +$2.77M 0.01% 738
2024
Q1
$40.8M Buy
+929,752
New +$38M 0.01% 661

Other funds holding CGON